SCHEMBL484754

SCHEMBL484754

O=C(Oc1nccc2cc(N3CCC4(CCNC4)CC3)ccc12)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
USP28 Q96RU2 1/20 0.37
PIM1 P11309 1/20 0.37
MCHR1 Q99705 1/20 0.36
CYP11B1 P15538 1/20 0.36
KHK P50053 1/20 0.35
ALK Q9UM73 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
C1S P09871 1/20 0.35
CCR4 P51679 1/20 0.35
NPY2R P49146 1/20 0.35
CYP2D6 P10635 2/20 0.34
TSHR P16473 2/20 0.34
HIF1A Q16665 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
KCNH2 Q12809 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485722 0.95 SOS1 (0.38) SOS1SLC6A2SLC6A4SLC6A3USP28
Trifluoroacetic Acid SCHEMBL484753 0.74 MMP2 (0.44) SOS1SLC6A2SLC6A4SLC6A3PIM1
SCHEMBL484729 0.71 SLC6A2 (0.45) SOS1SLC6A2SLC6A4SLC6A3PIM1
SCHEMBL13131256 0.69 SLC6A2 (0.44) SOS1SLC6A2SLC6A4SLC6A3PIM1
SCHEMBL13131249 0.69 CYP11B1 (0.51) SLC6A2SLC6A4SLC6A3PIM1CYP11B1
Hydrochloric Acid SCHEMBL2816087 0.68 SLC6A2 (0.44) SOS1SLC6A2SLC6A4SLC6A3PIM1
SCHEMBL485117 0.68 CYP2D6 (0.51) SOS1SLC6A2SLC6A4SLC6A3MCHR1
SCHEMBL6859491 0.66 CNR2 (0.52) TSHRCYP3A4
Trifluoroacetic Acid SCHEMBL2816008 0.66 HRH4 (0.49) PIM1MCHR1CYP11B1HRH3CYP2D6
Trifluoroacetic Acid SCHEMBL8511708 0.66 HDAC1 (0.39) SLC6A2SLC6A4SLC6A3NPY2RCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN SOS1 1709/4885SLC6A2 3182/4885SLC6A4 3132/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN SOS1 1709/4885SLC6A2 3182/4885SLC6A4 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.